Connect with us

Health & Fitness

COVID-19 Anticoagulation Trials ‘Paused’ for Futility, Safety

The REMAP-CAP, ACTIV-4 and ATTACC studies evaluating increased levels of anticoagulation in hospitalized COVID-19 patients have paused enrollment of patients treated in the ICU, the NHLBI confirms. Medscape Medical News

Published

on

COVID-19 Anticoagulation Trials ‘Paused’ for Futility, Safety